Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $3750.0000 (47.06%) ($3750.0000 - $3750.0000) on Thu. Jan. 22, 2004. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.67% (three month average) | RSI | 0 | Latest Price | $3750.0000(47.06%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 9.4% a day on average for past five trading days. | Weekly Trend | CAPR advances 5.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) TLT(2%) EWG(1%) EWP(1%) LQD(1%) REMX(1%) | Factors Impacting CAPR price | CAPR will decline at least -4.335% in a week (0% probabilities). EWY(-1%) EEM(-1%) XLY(-0%) XLU(-0%) XLK(-0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -4.335% (StdDev 8.67%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $2790(34.41%) | 10 Day Moving Average | $2681.87(39.83%) | 20 Day Moving Average | $2616.3(43.33%) | To recent high | 0% | To recent low | 47.1% | Market Cap | $73.866b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |